Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02688712
Title ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Providence Health & Services
Indications

rectum adenocarcinoma

Therapies

Capecitabine + Galunisertib

Fluorouracil + Galunisertib

Galunisertib

Fluorouracil

Capecitabine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.